James E. Thompson
Impact in
- Hematology top 2%
- Acute Myeloid Leukemia Research
- Cancer Research top 2%
- NF-κB Signaling Pathways
Papers in
-
- Melanoma and MAPK Pathways 12
- Histone Deacetylase Inhibitors Research 8
- Hematology 49
- Acute Myeloid Leukemia Research 35
- Chronic Myeloid Leukemia Treatments 22
- Co-authors
- Stephen C. Fry (4 shared papers)Paul Tempst (1 shared paper)Hediye Erdjument‐Bromage (1 shared paper)Sankar Ghosh (1 shared paper)Ronald T. Raines (5 shared papers)Craig B. Thompson (1 shared paper)Eunice S. Wang (40 shared papers)Dean Sheppard (7 shared papers)
- Journals
- Blood (25 papers)Bioorganic & Medicinal Chemistry Letters (13 papers)Leukemia Research (7 papers)Annals of Surgery (4 papers)Biochemistry (4 papers)
- Partner nations
- United StatesUnited KingdomIndia
In The Last Decade
James E. Thompson
144 papers receiving 4.8k citations
James E. Thompson's Hit Papers
Peers
Comparison fields: 5 of 172
- Hematology 585
- Cancer Research 641
- Immunology 699
- Molecular Biology 2.2k
- Genetics 287
Countries citing papers authored by James E. Thompson
This map shows the geographic impact of James E. Thompson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James E. Thompson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James E. Thompson more than expected).
Fields of papers citing papers by James E. Thompson
This network shows the impact of papers produced by James E. Thompson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James E. Thompson. The network helps show where James E. Thompson may publish in the future.
Co-authors
The 25 scholars most cited alongside James E. Thompson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 156 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | IκB-β regulates the persistent response in a biphasic activation of NF-κB Hit paper breakdown → | 1995 | 702 |
| 2 | 2001 | 254 | |
| 3 | 2002 | 228 | |
| 4 | 2004 | 184 | |
| 5 | 2000 | 155 | |
| 6 | 2001 | 153 | |
| 7 | 2000 | 137 | |
| 8 | 1981 | 132 | |
| 9 | 2005 | 130 | |
| 10 | 2005 | 122 | |
| 11 | 1994 | 118 | |
| 12 | 1994 | 111 | |
| 13 | 1988 | 108 | |
| 14 | 1987 | 100 | |
| 15 | 2018 | 100 | |
| 16 | 2012 | 91 | |
| 17 | 2009 | 87 | |
| 18 | 2010 | 87 | |
| 19 | 2011 | 85 | |
| 20 | 1995 | 74 |
About James E. Thompson
James E. Thompson is a scholar working on Molecular Biology, Hematology, Oncology, Organic Chemistry and Genetics, having authored 156 papers that have together received 5.0k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (35 papers), Chronic Myeloid Leukemia Treatments (22 papers), Melanoma and MAPK Pathways (12 papers), Acute Lymphoblastic Leukemia research (8 papers), Synthesis and biological activity (8 papers), Histone Deacetylase Inhibitors Research (8 papers), Chronic Lymphocytic Leukemia Research (8 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (7 papers). The work is most often cited by research in Hematology (585 citations), Cancer Research (641 citations), Immunology (699 citations), Molecular Biology (2.2k citations) and Genetics (287 citations). James E. Thompson has collaborated with scholars based in United States, United Kingdom and India. Frequent co-authors include Stephen C. Fry, Paul Tempst, Hediye Erdjument‐Bromage, Sankar Ghosh, Ronald T. Raines, Craig B. Thompson, Eunice S. Wang, Dean Sheppard, Martin Carroll and Meir Wetzler. Their work appears in journals such as Blood, Bioorganic & Medicinal Chemistry Letters, Leukemia Research, Annals of Surgery and Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.